Systemic Sclerosis: Immune Cell Link to Organ Damage
- Systemic sclerosis, a rare autoimmune disorder, manifests through skin hardening and Raynaud's phenomenon, causing color changes and numbness in fingers and toes during cold exposure.
- Now, a multi-institutional study spearheaded by the University of Osaka, published in Nature Communications, has pinpointed specific immune cells responsible for the varying degrees of disease severity in...
- To understand the variations in organ involvement among patients, researchers analyzed blood and tissue samples at the single-cell level, scrutinizing gene expression differences.They also examined cell surface proteins...
Groundbreaking research unveils the crucial link between immune cells and organ damage in systemic sclerosis.A new study details how specific immune cell subsets fuel the progression of this autoimmune disease,impacting the lungs and kidneys. Researchers pinpointed how the proliferation of immune cells directly correlates with the severity of the condition, paving the way for targeted therapies and earlier detection. By analyzing blood and tissue samples, experts identified biomarkers and pinpointed specific immune cells, including EGR1-expressing CD14+ monocytes, associated with detrimental outcomes in patients with systemic sclerosis. The research also highlighted the influence of CD8+ T cells in furthering lung complications. News Directory 3 keeps you abreast of the latest medical breakthroughs. Discover what’s next in the fight against systemic sclerosis.
Immune Cells drive Organ Damage in Systemic Sclerosis
Systemic sclerosis, a rare autoimmune disorder, manifests through skin hardening and Raynaud’s phenomenon, causing color changes and numbness in fingers and toes during cold exposure. Beyond these symptoms, internal organs like the lungs and kidneys can be affected, leading to severe health consequences.
Now, a multi-institutional study spearheaded by the University of Osaka, published in Nature Communications, has pinpointed specific immune cells responsible for the varying degrees of disease severity in systemic sclerosis patients. The research highlights how the proliferation of particular immune cells within key organs contributes to the condition’s progression.
To understand the variations in organ involvement among patients, researchers analyzed blood and tissue samples at the single-cell level, scrutinizing gene expression differences.They also examined cell surface proteins to identify disease biomarkers, which could aid in earlier diagnosis and treatment.
The team discovered that a subset of immune cells, specifically EGR1-expressing CD14+ monocytes, were strongly linked to scleroderma renal crisis, a serious kidney complication.In these instances,CD14+ monocytes transformed into destructive macrophages,promoting inflammation near the kidneys and contributing to the thickening and scarring of internal organs.
Additionally, CD8+ T cells with a type II interferon signature, known for their aggressive and inflammatory nature, were associated with progressive interstitial lung disease. Researchers believe these monocytes and T cells accumulate in the kidneys and lungs,respectively,producing factors that exacerbate disease progression.
“The results were intriguing,” said Masayuki Nishide, senior author. “We identified a specific subset of immune cells, the EGR1-expressing subpopulation of CD14+ monocytes, that were clearly associated with scleroderma renal crisis, a serious kidney complication in patients with systemic sclerosis.”
Hiroshi Shimagami,lead author,noted that the single-cell analysis revealed that specific abnormalities in distinct subsets of immune cells are associated with different clinical symptoms of systemic sclerosis,particularly organ manifestations.
What’s next
With limited treatment options currently available for systemic sclerosis, this study offers hope for new therapeutic strategies. Identifying biomarkers to predict disease progression and prevent severe organ involvement could significantly improve the quality of life for those affected by this condition.